Immune Biology of Retroviral Infection Section, Vaccine Branch, NCI, NIH, Bethesda, Maryland, USA.
Biostatistics and Data Management Section, NCI, NIH, Bethesda, Maryland, USA.
J Virol. 2019 Feb 5;93(4). doi: 10.1128/JVI.01687-18. Print 2019 Feb 15.
T follicular helper (T) cells are fundamental in germinal center (GC) maturation and selection of antigen-specific B cells within secondary lymphoid organs. GC-resident T cells have been fully characterized in human immunodeficiency virus (HIV) infection. However, the role of GC T cells in GC B cell responses following various simian immunodeficiency virus (SIV) vaccine regimens in rhesus macaques (RMs) has not been fully investigated. We characterized GC T cells of RMs over the course of a mucosal/systemic vaccination regimen to elucidate GC formation and SIV humoral response generation. Animals were mucosally primed twice with replicating adenovirus type 5 host range mutant (Ad5hr)-SIV recombinants and systemically boosted with ALVAC-SIVGag/Pro/gp120-TM and SIV gD-gp120 proteins formulated in alum hydroxide (ALVAC/Env) or DNA encoding SIVenv/SIVGag/rhesus interleukin 12 (IL-12) plus SIV gD-gp120 proteins formulated in alum phosphate (DNA&Env). Lymph nodes were biopsied in macaque subgroups prevaccination and at day 3, 7, or 14 after the 2nd Ad5hr-SIV prime and the 2nd vector/Env boost. Evaluations of GC T and GC B cell dynamics including correlation analyses supported a significant role for early GC T cells in providing B cell help during initial phases of GC formation. GC T responses at day 3 post-mucosal priming were consistent with generation of Env-specific memory B cells in GCs and elicitation of prolonged Env-specific humoral immunity in the rectal mucosa. GC Env-specific memory B cell responses elicited early post-systemic boosting correlated significantly with decreased viremia postinfection. Our results highlight the importance of early GC T cell responses for robust GC maturation and generation of long-lasting SIV-specific humoral responses at mucosal and systemic sites. Further investigation of GC T cell dynamics should facilitate development of an efficacious HIV vaccine. The modest HIV protection observed in the human RV144 vaccine trial associated antibody responses with vaccine efficacy. T follicular helper (T) cells are CD4 T cells that select antibody secreting cells with high antigenic affinity in germinal centers (GCs) within secondary lymphoid organs. To evaluate the role of T cells in eliciting prolonged virus-specific humoral responses, we vaccinated rhesus macaques with a combined mucosal prime/systemic boost regimen followed by repeated low-dose intrarectal challenges with SIV, mimicking human exposure to HIV-1. Although the vaccine regimen did not prevent SIV infection, decreased viremia was observed in the immunized macaques. Importantly, vaccine-induced T responses elicited at day 3 postimmunization and robust GC maturation were strongly associated. Further, early T-dependent SIV-specific B cell responses were also correlated with decreased viremia. Our findings highlight the contribution of early vaccine-induced GC T responses to elicitation of SIV-specific humoral immunity and implicate their participation in SIV control.
滤泡辅助 T 细胞(Tfh)在生发中心(GC)成熟和次级淋巴器官中抗原特异性 B 细胞的选择中起关键作用。GC 驻留 T 细胞在人类免疫缺陷病毒(HIV)感染中已得到充分描述。然而,在恒河猴(RMs)中,各种猴免疫缺陷病毒(SIV)疫苗方案中,GC T 细胞在 GC B 细胞反应中的作用尚未得到充分研究。我们在粘膜/系统疫苗接种方案过程中对 RMs 的 GC T 细胞进行了表征,以阐明 GC 的形成和 SIV 体液反应的产生。动物通过两次粘膜初免复制腺病毒 5 型宿主范围突变(Ad5hr)-SIV 重组体,并通过 ALVAC-SIVGag/Pro/gp120-TM 和 SIV gD-gp120 蛋白进行系统加强,这些蛋白以氢氧化铝(ALVAC/Env)或编码 SIVenv/SIVGag/rhesus 白细胞介素 12(IL-12)的 DNA 以及 SIV gD-gp120 蛋白的形式配制在磷酸铝(DNA&Env)中。在第二次 Ad5hr-SIV 初免和第二次载体/Env 加强后的第 2 天、第 3 天、第 7 天或第 14 天,对猕猴亚组的淋巴结进行活检。对 GC T 和 GC B 细胞动力学的评估,包括相关性分析,支持早期 GC T 细胞在 GC 形成的初始阶段为 B 细胞提供帮助的重要作用。粘膜初免后第 3 天的 GC T 反应与 GC 中 Env 特异性记忆 B 细胞的产生以及直肠粘膜中延长的 Env 特异性体液免疫的产生一致。早期系统加强后 GC Env 特异性记忆 B 细胞反应与感染后病毒载量降低显著相关。我们的结果强调了早期 GC T 细胞反应对于在粘膜和全身部位产生强大的 GC 成熟和持久的 SIV 特异性体液反应的重要性。进一步研究 GC T 细胞动力学应有助于开发有效的 HIV 疫苗。人类 RV144 疫苗试验中观察到的适度 HIV 保护作用与疫苗功效相关联的抗体反应。滤泡辅助 T(Tfh)细胞是 CD4 T 细胞,在次级淋巴器官的生发中心(GC)中选择具有高抗原亲和力的抗体分泌细胞。为了评估 T 细胞在引发延长的病毒特异性体液反应中的作用,我们用粘膜初免/系统加强方案对恒河猴进行了疫苗接种,然后用 SIV 重复进行低剂量直肠内挑战,模拟人类接触 HIV-1。虽然疫苗方案不能预防 SIV 感染,但免疫猕猴的病毒载量降低。重要的是,疫苗接种后第 3 天诱导的 T 反应与强烈相关。此外,早期依赖 T 的 SIV 特异性 B 细胞反应也与病毒载量降低相关。我们的发现强调了早期疫苗诱导的 GC T 反应对 SIV 特异性体液免疫的激发作用,并表明它们参与了 SIV 的控制。